HALO

Halozyme Therapeutics, Inc. - Common Stock

$20.80 +$1.23 +5.91%



Shares Bought7
Shares Sold7
Total14
Shares Owned0
Last Price$20.80
Total Return-$4.30
Range Today$19.52 - $20.91
52 Week Range$9.68 - $20.91
Open$19.53
Market Cap$2.78B
Volume/Average987.80K/1.41M
P/E Ratio-
Dividend/Yield-




Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
11-22-17 21:05 11-27-17 18:50 $18.26 $18.89 +$0.63 +3.45% michrob
10-19-17 20:35 10-20-17 17:13 $17.90 $17.84 -$0.06 -0.34% funkmasterflexion michrob
06-26-17 20:17 07-24-17 17:24 $14.69 $13.54 -$1.15 -7.83% fgtdog radiatoren buyandsell123 rigawest nyacide acewingman allegedly_banned
06-26-17 19:26 07-19-17 19:06 $14.54 $13.01 -$1.53 -10.52% radiatoren mitchtriestwitch jordanpoet rigawest
06-26-17 19:21 07-19-17 19:01 $14.56 $13.01 -$1.55 -10.64%
06-27-17 13:10 07-25-17 15:43 $14.70 $13.41 -$1.29 -8.77% pezination
11-22-17 20:59 11-27-17 18:49 $18.25 $18.89 +$0.64 +3.54% funkmasterflexion